Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Investments That Profit From Inflation
http://seekingalpha.com/article/264577-investments-that-profit-from-inflation
Big U.S. Firms Shift Hiring Abroad
Work Forces Shrink at Home, Sharpening Debate on Economic Impact of Globalization
http://online.wsj.com/article/SB10001424052748704821704576270783611823972.html
CEOs earn 343 times more than typical workers
http://money.cnn.com/2011/04/19/news/economy/ceo_pay/index.htm
The 10 Most Prescribed Drugs/The 10 Best-Selling Drugs
Hydrocodone (combined with acetaminophen) -- 131.2 million prescriptions
Generic Zocor (simvastatin), a cholesterol-lowering statin drug -- 94.1 million prescriptions
Lisinopril (brand names include Prinivil and Zestril), a blood pressure drug -- 87.4 million prescriptions
Generic Synthroid (levothyroxine sodium), synthetic thyroid hormone -- 70.5 million prescriptions
Generic Norvasc (amlodipine besylate), an angina/blood pressure drug -- 57.2 million prescriptions
Generic Prilosec (omeprazole), an antacid drug -- 53.4 million prescriptions (does not include over-the-counter sales)
Azithromycin (brand names include Z-Pak and Zithromax), an antibiotic -- 52.6 million prescriptions
Amoxicillin (various brand names), an antibiotic -- 52.3 million prescriptions
Generic Glucophage (metformin), a diabetes drug -- 48.3 million prescriptions
Hydrochlorothiazide (various brand names), a water pill used to lower blood pressure -- 47.8 million prescriptions.
The IMS reports that Americans spent $307 billion on prescription drugs in 2010.
The 10 drugs on which we spent the most were:
Lipitor, a cholesterol-lowering statin drug -- $7.2 billion
Nexium, an antacid drug -- $6.3 billion
Plavix, a blood thinner -- $6.1 billion
Advair Diskus, an asthma inhaler -- $4.7 billion
Abilify, an antipsychotic drug -- $4.6 billion
Seroquel, an antipsychotic drug -- $4.4 billion
Singulair, an oral asthma drug -- $4.1 billion
Crestor, a cholesterol-lowering statin drug -- $3.8 billion
Actos, a diabetes drug -- $3.5 billion
Epogen, an injectable anemia drug -- $3.3 billion
http://www.webmd.com/news/20110420/the-10-most-prescribed-drugs
IPCI 3.11 Intellipharmaceutics - Pipeline & Rexista
http://www.intellipharmaceutics.com/pipeline.cfm
Rexista™ (Oxycodone) "One of our key non-generic development products is Rexista™, an abuse- and alcohol-resistant, controlled-release oral oxycodone formulation. This product is covered by pending patent applications. Rexista™ is a unique dosage form, designed to be resistant to well-documented abuse that is experienced with current oxycodone products."
The pilot clinical trial produced the following results:
The Rexista™ product demonstrated sustained release pharmacokinetic activity, with blood plasma concentrations at clinically significant levels over a 24 hour period.
The bioavailability of a single dose of the Rexista™ product, as measured by Cmax and AUC, was comparable to that of two doses of Oxycontin® dosed at 12 hour intervals. Both Cmax and AUC were in the 80% - 125% range as compared to Oxycontin®, demonstrating effective bioequivalence with the branded product.
Due to the growing abuse associated with certain painkillers, in February 2009 the FDA announced that it plans to implement a Risk Evaluation and Mitigation Strategy (REMS) requirement for all extended-release opioid analgesics. The REMS plan is driving current R&D efforts and may ultimately drive prescribing of newer tamper-resistant extended-release opioids. We believe that the FDA's move to restrict prescribing of extended-release opioid analgesics should benefit tamper-resistant formulations such as Rexista™.
http://www.intellipharmaceutics.com/oxycodone.cfm
Re/Max CEO Margaret Kelly: We've Been Wrong Every Month For 5 Years, But Now Is REALLY The Time To Buy (Bloomberg Interview)
http://www.bloomberg.com/news/2011-04-20/u-s-existing-home-sales-rise-fail-to-recover-ground-lost.html
Jim Rogers on chances of $100+ Silver in 2011
Project Gunrunner
America’s Most Popular Drugs
2010 1-year growth (%) 5-year growth (%)
Drug (brand name) use 3995.2 1.16% 7.79%
1 hydrocodone/acetaminophen (Vicodin) pain 131.2 2.34% 16.73%
2 simvastatin (Zocor) high cholesterol 94.1 12.29% 553.47%
3 lisinopril high blood pressure 87.4 5.56% 34.05%
4 levothyroxine sodium (Synthroid) hypothyroid 70.5 6.82% 41.57%
5 amlodipine besylate (Norvasc) high blood pressure. 57.2 11.50% NA
6 omeprazole (Prilosec) acid reflux 53.4 17.62% 196.67%
7 azithromycin (Zithromax) antibiotic 52.6 -2.23% 44.11%
8 amoxicillin antibiotic 52.3 -0.19% -4.39%
9 metformin HCL (Glucophage) diabetes 48.3 9.03% 25.78%
10 hydrochlorothiazide high blood pressure 47.8 -0.21% -0.42%
11 alprazolam (Xanax) anxiety 46.3 5.47% 23.14%
12 Lipitor (atorvastatin) high cholesterol 45.3 -12.38% -38.78%
13 furosemide high blood pressure 43.4 -0.23% -2.03%
14 metoprolol tartrate (Lopressor) high blood pressure
38.9 -5.35% 33.22%
15 zolpidem tartrate (Ambien) insomnia 38 8.26% NA
16 atenolol high blood pressure 36.3 -7.63% -21.26%
17 sertraline HCL (Zoloft) depression 35.7 4.39% 230.56%
18 metoprolol succinate (Toprol) blood pressure 33 22.68% 5400.00%
19 citalopram (Celexa) depression 32.1 18.45% 129.29%
20 warfarin sodium (Coumadin) blood thinner 32 1.27% 19.85%
21 oxycodone/acetaminophen pain 31.9 5.63% 39.91%
22 ibuprofen pain 31.1 2.64% 16.04%
23 Plavix (clopidogrel) heart disease 29.5 -1.34% 60.33%
24 gabapentin (Neurontin) 29.3 15.35% 58.38%
25 Singulair (montelukast) allergies
28.7 0.35% 2.14%
http://blogs.forbes.com/matthewherper/2011/04/19/americas-most-popular-drugs/
16 Small Caps With Cash to Cover 1+ Years of Operating Expenses
http://seekingalpha.com/article/264337-16-small-caps-with-cash-to-cover-1-years-of-operating-expenses
OSUR 8.58 OraSure Technologies - OraSure Technologies Earnings Conference Call Invitation
2011 First Quarter Earnings Conference Call Wednesday, May 4, 2011, 5:00 p.m. ET
BETHLEHEM, Pa., April 20, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR - News) has scheduled its regular earnings conference call covering 2011 first quarter financial results and certain 2011 financial guidance for 5:00 pm ET (2:00 pm PT) on Wednesday, May 4, 2011. An update on certain business developments will also be provided.
May 4, 2011 Schedule
4:00 p.m. ET 2011 first quarter financial results will be distributed by GlobeNewswire
4:50 p.m. ET
To participate in the conference call, dial 877-348-9357 (Domestic) or 970-315-0488
(International) and reference Conference ID #61775799.
5:00 p.m. ET Conference call and simultaneous Webcast begins
The conference call will also be webcast live and may be accessed on the Investor Relations page of OraSure's website, www.orasure.com. Please click on the webcast link and follow the prompts for registration and access 10 minutes prior to the call.
If you are unable to participate, a replay of the call will be archived on OraSure's website shortly after the call has ended and will be available for seven days. A replay of the call can also be accessed until midnight, May 11, 2011 by dialing 800-642-1687 (Domestic) or 706-645-9291 (International) and entering the Conference ID # 61775799.
http://finance.yahoo.com/news/OraSure-Technologies-Earnings-pz-424880102.html?x=0&.v=1
OSUR 8.58 OraSure Technologies - OraSure Technologies Earnings Conference Call Invitation
2011 First Quarter Earnings Conference Call Wednesday, May 4, 2011, 5:00 p.m. ET
BETHLEHEM, Pa., April 20, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR - News) has scheduled its regular earnings conference call covering 2011 first quarter financial results and certain 2011 financial guidance for 5:00 pm ET (2:00 pm PT) on Wednesday, May 4, 2011. An update on certain business developments will also be provided.
May 4, 2011 Schedule
4:00 p.m. ET 2011 first quarter financial results will be distributed by GlobeNewswire
4:50 p.m. ET
To participate in the conference call, dial 877-348-9357 (Domestic) or 970-315-0488
(International) and reference Conference ID #61775799.
5:00 p.m. ET Conference call and simultaneous Webcast begins
The conference call will also be webcast live and may be accessed on the Investor Relations page of OraSure's website, www.orasure.com. Please click on the webcast link and follow the prompts for registration and access 10 minutes prior to the call.
If you are unable to participate, a replay of the call will be archived on OraSure's website shortly after the call has ended and will be available for seven days. A replay of the call can also be accessed until midnight, May 11, 2011 by dialing 800-642-1687 (Domestic) or 706-645-9291 (International) and entering the Conference ID # 61775799.
http://finance.yahoo.com/news/OraSure-Technologies-Earnings-pz-424880102.html?x=0&.v=1
US farmers threaten by worst drought since 1930's
http://thewatchers.adorraeli.com/2011/04/15/us-farmers-threaten-by-worst-drought-since-1930s/
Gold Tops $1,500 on Outlook for Escalating U.S. Debt, Dollar
http://www.bloomberg.com/news/2011-04-19/gold-futures-top-1-500-on-outlook-for-escalating-u-s-debt-dollar-slump.html
Debt warning rocks US economy
http://www.activistpost.com/2011/04/debt-warning-rocks-us-economy.html
6 Cash Rich Biotech Stocks With Catalysts
http://seekingalpha.com/article/262559-6-cash-rich-biotech-stocks-with-catalysts
IPCI 2.99 Intellipharmaceutics - Now has five ANDAs awaiting FDA approval
http://biomedreports.com/2011040465637/now-five-andas-awaiting-fda-approval.html
Intellipharmaceutics Announces First Quarter 2011 Results
http://finance.yahoo.com/news/Intellipharmaceutics-pz-1800402590.html?x=0&.v=1
Throw Out the Money Changers
By Chris Hedges at Union Square in New York City last Friday during a protest outside a branch office of the Bank of America.
RPTP 3.44 Raptor Pharmaceuticals - Raptor Pharma's Upcoming Catalysts
http://au.quote.com/news/story.action?id=RTT104190607000349&pg=1
UK private security firms eye Libya as new cash cow
Workforce in U.S. Drops to 27-Year Low
http://www.usatoday.com/money/economy/employment/2011-04-13-more-americans-leave-labor-force.htm
PATH 6.70 NuPathe - My speculation, With Zelrix PDUFA date for the NDA being August 29, the recent drift down may be because the next catalyst date has been too far off for most shorter-term bio traders. Watching it on the streamer, it's been a thin-mover in either direction. Ive been out since it failed to hold support in the 8's, but have been keeping an eye on it for reentry.
Kiss Cam Operator Last Day
Scientists warn that drugs of the future will be designed specifically to control the human mind
http://www.theage.com.au/technology/sci-tech/racist-angry-the-answer-may-be-in-a-pill-20110407-1d5c9.html
B. Gates is starting to remind me of Bernie Sanders. Sometimes intelligent and insightful, sometimes an utter whack-job.
If votes of the people actually do count, Obama has nearly zero chance of re-election. He has screwed everyone but the tiny elite class.
Steal Billions Like Dimon, Blankfein And You're Doing God's Work, Sell $31 Of Pot And Go To Jail For 10 Years
Oklahoma Mom Gets 10 Years for Selling $31 of Marijuana
http://www.aolnews.com/2011/02/21/oklahoma-mom-patricia-marilyn-spottedcrow-gets-10-years-for-sell/
LXRX 1.69 Lexicon Pharmaceuticals -
"plans to report Phase 2a results for LX1032 for controlling symptoms associated with carcinoid syndrome and the complementary open-label clinical trial results in 2Q 2011. It will also be initiating a phase 2b study of LX4211 for type 2 diabetes in late 2Q or early 3Q 2011. The phase 2a results for LX4211 indicated statistically significant and rapid improvements in several areas in patients with type 2 diabetes, including significant reductions of HbA1c within four weeks. A separate LX4211 tablet formulation mechanistic study also indicated increased levels of GLP-1 and PYY, important mediators of glycemic and appetite control. The potential market for LX4211 is obviously huge, and investors will be anxiously awaiting results for this study whenever it completes. A relatively under the radar company, Lexicon has drug discovery alliances with Bristol-Myers Squibb (BMY), Genentech, N.V. Organon, and Takeda Pharmaceutical Company Limited (TKPYY.PK). Not only will investors be evaluating these results closely, but also some key players in larger pharmaceuticals with close ties to Lexicon."
http://seekingalpha.com/article/263265-upcoming-biotech-trials-and-potential-tribulations
RPTP 3.25 Raptor Pharmaceuticals - Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
http://ih.advfn.com/p.php?pid=nmona&article=47275534
CBS 60 Minutes- The Second Mortgage Meltdown Crisis
Now that Trump has announced his candidacy, In idiot America where celebrity = royalty, Jesse Ventura as a running mate has even more merit.
Harry Dent: “Major Crash” Coming for Stocks, Commodities Already Topping Out
http://finance.yahoo.com/blogs/daily-ticker/harry-dent-major-crash-coming-stocks-commodities-already-20110331-080715-415.html
Keiser Report: Cocaine Makes World Go Round (E136)
Government Shutdown 2011? – 16 Things You Need To Know
#1 Hundreds of thousands of "non-essential" federal workers will be told to stay home during a government shutdown.
#2 Those in the military will not receive paychecks during a government shutdown but they will be required to keep performing their duties.
#3 The Obama administration is anticipating "significantly lower staffing levels" at the White House if a shutdown happens.
#4 Barack Obama will continue to be paid during a government shutdown.
#5 Congress will also be paid and will continue to operate at close to normal levels during a government shutdown.
#6 The Federal Reserve will continue to operate normally during a government shutdown. The Federal Reserve is not part of the U.S. government.
#7 In all probability, all government employees will eventually receive any pay that is missed during a government shutdown. During the 5 day U.S. government shutdown back in 1995, approximately 800,000 "non-essential" government employees were told not to come in to work. But eventually they all got paid retroactively anyway.
#8 During a government shutdown, the Department of Homeland Security will suspend operation of its e-Verify system. Employers will be unable to verify the immigration status of job applicants and that could have a substantial negative impact on hiring.
#9 The processing of small business loans and FHA mortgages will be delayed during a government shutdown.
#10 The U.S. Postal Service will not be affected by a government shutdown. You will continue to get your mail.
#11 According to the Social Security Administration, everyone that is currently receiving Social Security benefits will continue to receive those benefits during a shutdown. New applications will be delayed however.
#12 Medicare payments will continue during a government shutdown, but there will be a delay in processing new applications.
#13 During a government shutdown, the processing of paper tax returns by the IRS would be delayed.
#14 If there is a government shutdown, the processing of passport and visa applications could be seriously delayed. This could have a negative impact on the tourism industry.
#15 National parks, museums and tourist attractions will be shut down. According to the Washington Post, "about 500,000 visitors could be turned away this weekend alone from the National Zoo and the major Smithsonian museums on the Mall".
#16 The annual Cherry Blossom Festival parade in Washington D.C. that is scheduled for this weekend would be cancelled.
http://endoftheamericandream.com/archives/government-shutdown-2011-16-things-you-need-to-know
Bring on QE3! “We Can’t Afford NOT to Do More,” Romer Says
http://finance.yahoo.com/blogs/daily-ticker/bring-qe3-t-afford-not-more-romer-says-20110407-045249-959.html
Latest Earthquakes
MAP 7.4 2011/04/07 14:32:42 38.253 141.640 25.6 NEAR THE EAST COAST OF HONSHU, JAPAN
MAP 7.4 2011/04/07 14:32:00 38.200 142.000 40.0 NEAR THE EAST COAST OF HONSHU, JAPAN
MAP 6.5 2011/04/07 13:11:25 17.431 -93.978 167.4 VERACRUZ, MEXICO
MAP 5.1 2011/04/07 07:16:12 -42.228 177.490 14.1 OFF EAST COAST OF THE SOUTH ISLAND, N.Z.
http://earthquake.usgs.gov/earthquakes/recenteqsww/Quakes/quakes_big.php
Biotech Catalysts for Q2 2011
http://seekingalpha.com/article/262302-biotech-catalysts-for-q2-2011
Washington Post and CBS receiving money from Obamacare slush fund
"The Washington Post Company raked in $573,217 in taxpayer subsidies and CBS Corporation secured $722,388 worth of Americans’ money."
http://dailycaller.com/2011/04/06/washington-post-and-cbs-receiving-money-from-obamacare-slush-fund/
African migrants abandon the American dream
(snippet)
The American dream is not all it is cut out to be and some Africans
are turning their backs on life in the US.
It is impossible to say how many returnees there are, as the evidence is anecdotal but representatives of African community associations in New York, Atlanta and Boston all say they know of large numbers of expatriates making plans to leave the US.
The reason: they cannot find jobs and have become desperate about their future here.
http://www.bbc.co.uk/news/world-africa-12810828